"New Perspectives of Adaptation to NIV in ALS"

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

January 31, 2018

Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
OTHER

Adaptation and training to Non Invasive Ventilation (NIV)

Each person recruited after a respiratory evaluation (baseline spirometry and supine, maximal inspiratory and expiratory pressures (MIP / MEP) or sniff nasal inspiratory pressure (SNIP), 6 Minute Walking Test (6MWT) -if still ambulatory, arterial blood gas, nocturnal polygraphy) will be adapted to Non Invasive Ventilation (NIV). Moreover, the subject will be brought to the management of bronchial secretions (under the terms set out herein) during not less than five outpatient or house accesses, depending on who is randomly assigned to the experimental group or the control group. These accesses will take place weekly, for a period of two months, considering both the needs and the patient's clinical condition.

Trial Locations (2)

20149

Paolo Banfi, Milan

25065

Michele Vitacca, Lumezzane

All Listed Sponsors
collaborator

Fondazione Salvatore Maugeri

OTHER

lead

Fondazione Don Carlo Gnocchi Onlus

OTHER

NCT02537132 - "New Perspectives of Adaptation to NIV in ALS" | Biotech Hunter | Biotech Hunter